Featured Posts
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…
Newsletter
Global Warming Apathy, Pelosi on Oil Drilling and Government Health Care
A new survey suggests that public concern about global warming is on the decline. House Speaker Nancy Pelosi reverses her opposition to a vote on…
Study
FDA’s Bad Medicine
How the dispersed knowledge problem affects drug safety analysis and how markets and technology will help patients…
Newsletter
Losses at Fannie Mae, Satellite TV Merger and Toxic Chemicals
Mortgage giant Fannie Mae reports a loss of $2.3 billion. Cable TV provider Dish Network proposes a merger with DirecTV. Former New York Times environmental…